* Board approved an investment of up to 10% of the shares of Cancer Care Kenya Limited (CCK). * Approved the issuance of a guarantee in the form of a Standby Letter of Credit (SBLC) to secure credit facilities proposed to be availed by CCK for its business expansion. * CCK's turnover for the financial year ended March 31, 2025, was ₹42.53 Crore and Profit After Tax of ₹10.83 Crore. * The investment will be completed on or before March 31, 2026. * The cost of acquisition of the shares of CCK shall be up to ₹7 Crore (approx.). * CCK proposes to raise about USD 1.8 million (approximately ₹16 Crore) as a term loan, backed by a Standby Letter of Credit (SBLC) to be issued out of the existing credit facilities of the Company. * The Company’s potential liability under the guarantee could be up to 105% of the outstanding loan of CCK under this arrangement.
